System and method for assessing cardiac performance through cardiac vibration monitoring

• US 8,888,710 B2
• Filed: 08/12/2011
• Issued: 11/18/2014
• Est. Priority Date: 02/19/2004
• Status: Active Grant

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Wariar, Ramesh, Carlson, Gerrard M.
• Primary Examiner(s): D'ANGELO, MICHAEL J
• Application Number:
  US13/208,722
• Publication Number:
  US 20110301473A1
• Time in Patent Office: 1,194 Days
• Field of Search: 600/481, 600/300, 600/483, 600/485, 600/528, 600/508
• US Class Current: 600/528
• CPC Class Codes: A61B 5/021 Measuring pressure in heart or blood vessels A61B5/0205 takes precedence
• CPC Class Codes: A61B 7/00 Instruments for auscultation
• CPC Class Codes: A61B 7/04 Electric stethoscopes microphones, acoustic transducers therefor H04R

Abstract

A system and method for assessing cardiac performance through cardiac vibration monitoring is described. Cardiac vibration measures are directly collected through an implantable medical device. Cardiac events including at least one first heart sound reflected by the cardiac vibration measures are identified. The first heart sound is correlated to cardiac dimensional measures relative to performance of an intrathoracic pressure maneuver. The cardiac dimensional measures are grouped into at least one measures set corresponding to a temporal phase of the intrathoracic pressure maneuver. The at least one cardiac dimensional measures set is evaluated against a cardiac dimensional trend for the corresponding intrathoracic pressure maneuver temporal phase to represent cardiac performance.

Claims

1. A system for evaluating cardiac performance relative to performance of an intrathoracic pressure maneuver, comprising:

an implantable medical device to indirectly sense heart sounds by directly collecting cardiac vibration measures; and

an analysis component to evaluate cardiac functional changes to the heart sounds in response to performance of an intrathoracic pressure maneuver, wherein ventricular preload is measured to correct S1 heart sound intensity for preload variations.

2. A system according to claim 1, further comprising:

an evaluation component to evaluate the heart sounds to derive cardiac chamber pressure, wherein the cardiac chamber pressure comprises at least one of left ventricular ejection fraction, left ventricular end diastolic pressure, pulmonary capillary wedge pressure, pulmonary artery pressure, and an S3 index of pressure.

3. A system according to claim 1, wherein the implantable medical device comprises at least one of a cardiac pacemaker, cardioverter defibrillator, cardiac resynchronization device, cardiovascular monitor, and therapeutic device monitoring and treating structural problems of the heart.

4. A system according to claim 1, wherein heart sounds comprising cardiac events for at least one of intensity of a first heart sound, ratio of first heart sound energy to total energy, and ratio of first heart sound intensity to pulmonary artery pressure are determined.

5. A system according to claim 1, wherein the intrathoracic pressure maneuver comprises at least one of a Valsalva and Mü

ller maneuver.

6. A system according to claim 1, further comprising:

at least one of;

an evaluation subcomponent to evaluate at least one of overdamping and underdamping cardiac impedance response relative to normative levels; and

a notification subcomponent to generate a notification responsive to the at least one of overdamping and underdamping cardiac impedance response.

7. A system according to claim 1, wherein thoracic pressure is monitored during the intrathoracic pressure maneuver, further comprising:

an external pressure monitor to define a confined volume configured to receive at least one of a forced exhalation and a forced inhalation and to measure the thoracic pressure relative to the confined volume.

8. A system according to claim 1, wherein the cardiac vibrations are selected from the group comprising auscultatory, sub-audible, and detectable cardiac events.

9. A method for evaluating cardiac performance relative to performance of an intrathoracic pressure maneuver, comprising:

indirectly sensing heart sounds by directly collecting cardiac vibration measures through an implantable medical device;

a processor evaluating cardiac functional changes to the heart sounds in response to performance of an intrathoracic pressure maneuver; and

measuring ventricular preload to correct S1 heart sound intensity for preload variations.

10. A method according to claim 9, further comprising:

evaluating the heart sounds to derive cardiac chamber pressure, wherein the cardiac chamber pressure comprises at least one of left ventricular ejection fraction, left ventricular end diastolic pressure, pulmonary capillary wedge pressure, pulmonary artery pressure, and an S3 index of pressure.

11. A method according to claim 9, wherein the medical device comprises at least one of a cardiac pacemaker, cardioverter defibrillator, cardiac resynchronization device, cardiovascular monitor, and therapeutic device monitoring and treating structural problems of the heart.

12. A method according to claim 9, further comprising:

determining heart sounds comprising cardiac events for at least one of intensity of a first heart sound, ratio of first heart sound energy to total energy, and ratio of first heart sound intensity to pulmonary artery pressure.

13. A method according to claim 9, wherein the intrathoracic pressure maneuver comprises at least one of a Valsalva and Mü

ller maneuver.

14. A method according to claim 9, further comprising:

performing at least one of;

evaluating at least one of overdamping and underdamping cardiac impedance response relative to normative levels; and

generating a notification responsive to the at least one of overdamping and underdamping cardiac impedance response.

15. A method according to claim 9, further comprising:

monitoring thoracic pressure during the intrathoracic pressure maneuver;

defining a confined volume configured to receive at least one of a forced exhalation and a forced inhalation; and

measuring the thoracic pressure relative to the confined volume.

16. A method according to claim 9, wherein the cardiac vibrations are selected from the group comprising auscultatory, sub-audible, and detectable cardiac events.

17. A non-transitory computer-readable storage medium holding code for performing the method of claim 9.

18. A system for evaluating cardiac performance relative to performance of an intrathoracic pressure maneuver, comprising:

an implantable medical device to indirectly sense heart sounds by directly collecting cardiac vibration measures; and

an analysis component to evaluate cardiac functional changes to the heart sounds in response to performance of an intrathoracic pressure maneuver, wherein thoracic pressure is monitored during the intrathoracic pressure maneuver; and

an external pressure monitor to define a confined volume configured to receive at least one of a forced exhalation and a forced inhalation and to measure the thoracic pressure relative to the confined volume.

19. The system of claim 18, wherein ventricular preload is measured to correct S1 heart sound intensity for preload variations.